Biocept, Inc.
BIOCQ
$0.00
$0.000.00%
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 63.85% | -223.26% | -226.76% | -2,197.28% | -449.81% |
| Total Depreciation and Amortization | 4,211.11% | -25.03% | 166.06% | -46.52% | -101.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -278.08% | -82.04% | -70.69% | -81.86% | 69.25% |
| Change in Net Operating Assets | -67.18% | 101.54% | 36.02% | 740.96% | 99.57% |
| Cash from Operations | 23.61% | -564.59% | -371.23% | -494.89% | -305.39% |
| Capital Expenditure | 55.30% | 7.14% | 76.95% | -137.33% | -80.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 89.86% | 7.14% | 76.95% | -137.33% | -80.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.42% | 12.69% | -66.74% | -25.45% | 6.50% |
| Issuance of Common Stock | 3,685.11% | -- | -99.84% | -98.49% | -97.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 878.74% | 160.45% | -488.54% | -105.24% | -111.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.96% | -371.73% | -539.45% | -159.50% | -188.29% |
